Comments on: Novartis gets EU endorsement for Revolade as first-in-class treatment for youngsters matured 1 year or more with constant ITP

Comments on: Novartis gets EU endorsement for Revolade as first-in-class treatment for youngsters matured 1 year or more with constant ITP https://apnipsp.net/health/novartis-gets-eu-endorsement-for-revolade-as-first-in-class-treatment-for-youngsters-matured-1-year-or-more-with-constant-itp/ Technology News , Health News & Tips, National & International News, Video News Sat, 09 Apr 2016 10:09:48 +0000 hourly 1 https://wordpress.org/?v=5.8.4